Merck (MRK) Revenue (2009 - 2026)
Merck (MRK) posted quarterly Revenue of $16.3 billion for Q1 2026, up 4.87% year-over-year from $15.5 billion in Q1 2025, and down 0.7% quarter-over-quarter from $16.4 billion in Q4 2025.
Merck (MRK) Revenue (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Revenue for 18 consecutive years, with $16.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 4.87% year-over-year to $16.3 billion; the TTM figure through Mar 2026 stood at $65.8 billion (up 2.89% YoY), while the FY2025 annual figure was $65.0 billion, up 1.31% from the prior year.
- Revenue retreated to $16.3 billion in Q1 2026 per MRK's latest filing, from $16.4 billion in the prior quarter.
- Across five years, Revenue topped out at $17.3 billion in Q3 2025 and bottomed at $13.8 billion in Q4 2022.
- Historically, Revenue has averaged $15.6 billion across 5 years, with a median of $15.8 billion in 2024.
- Annual changes were most pronounced in 2022 — Revenue jumped 49.63% — and 2023, when it dropped 8.89%.
- Merck's Revenue stood at $13.8 billion in 2022, then advanced by 5.78% to $14.6 billion in 2023, then grew by 6.79% to $15.6 billion in 2024, then increased by 4.97% to $16.4 billion in 2025, then fell by 0.7% to $16.3 billion in 2026.
- Business Quant data shows MRK's Revenue at $16.3 billion in Q1 2026, $16.4 billion in Q4 2025, and $17.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 13.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.61 Bn |
| Mar 31, 2026 | 16.29 Bn |
| Dec 31, 2025 | 16.40 Bn |
| Sep 30, 2025 | 17.28 Bn |
| Jun 30, 2025 | 15.81 Bn |
| Mar 31, 2025 | 15.53 Bn |
| Dec 31, 2024 | 15.62 Bn |
| Sep 30, 2024 | 16.66 Bn |
| Jun 30, 2024 | 16.11 Bn |
| Mar 31, 2024 | 15.78 Bn |
| Dec 31, 2023 | 14.63 Bn |
| Sep 30, 2023 | 15.96 Bn |
| Jun 30, 2023 | 15.04 Bn |
| Mar 31, 2023 | 14.49 Bn |
| Dec 31, 2022 | 13.83 Bn |
| Sep 30, 2022 | 14.96 Bn |
| Jun 30, 2022 | 14.59 Bn |
| Mar 31, 2022 | 15.90 Bn |
| Dec 31, 2021 | 13.52 Bn |
| Sep 30, 2021 | 13.15 Bn |